✦ LIBER ✦

AN OPEN, RANDOMIZED, CONTROLLED COMPARISON OF LONG-ACTING INJECTABLE RISPERIDONE VS. ORAL OLANZAPINE IN SCHIZOPHRENIA & SCHIZOAFFECTIVE DISORDER

✍ Scribed by Nicholas A. Keks

Book ID: 119557730
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 68 KB
Volume: 136
Category: Article
ISSN: 0920-9964
DOI: 10.1016/s0920-9964(12)70017-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relapse Prevention in Schizophrenia and

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

✍ Gaebel, Wolfgang; Schreiner, Andreas; Bergmans, Paul; de Arce, Rosario; Rouillon 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 486 KB

P.3.c.011 Olanzapine long-acting injecti

P.3.c.011 Olanzapine long-acting injection vs oral olanzapine in schizophrenia outpatients: a 2-year, randomized, open-label study

✍ H. Detke; P.J. Weiden; T. Lambert; P.M. Llorca; M. Choukour; S.B. Watson; E. Bru 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

P03-21 Relapse prevention in schizophren

P03-21 Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable versus quetiapine: Randomized, long-term, open-label, clinical trial results (ConstaTRE)

✍ Gaebel, W.; Bergmans, P.; de Arce, R.; Rouillon, F.; Cordes, J.; Eriksson, L.; S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 French ⚖ 46 KB

Comparison of metabolic changes in patie

Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long-acting injection versus oral olanzapine

✍ David P. McDonnell; Ludmila A. Kryzhanovskaya; Fangyi Zhao; Holland C. Detke; Pe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 1 views

Metabolic changes were examined in patients with schizophrenia during treatment with either oral olanzapine or olanzapine long‐acting injection (LAI). Data were collected from patients who had been stabilized on oral olanzapine (10, 15, or 20 mg/day) for ≥4 weeks and then randomized to either contin

A 6-month randomized open-label comparis

A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder

✍ L. N. Yatham; A. Fallu; C. E. Binder 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

TREATMENT COMPLETION RATES OF OLANZAPINE

TREATMENT COMPLETION RATES OF OLANZAPINE AND RISPERIDONE IN LONG ACTING INJECTABLE FORMULATIONS FOR THE TREATMENT OF SCHIZOPHRENIA: A COMPARISON OF SINGLE ARM OPEN-LABEL STUDIES

✍ Haya Ascher-Svanum; William Montgmery; Allen Brnabic; Anthony Lawson; Oladapo To 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB